TNF-Alpha rs1800629 Polymorphism Is Not Associated with HPV Infection or Cervical Cancer in the Chinese Population

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Wang, Ning ^a   Yin, Duo ^a   Zhang, Shulan ^a   Wei, Heng ^a   Wang, Shizhuo ^a   Zhang, Yang ^a   Lu, Yanming ^a   Dai, Shuyan ^a   Li, Wei ^a   Zhang, Qiao ^a   Zhang, Yao ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; CANCER RISK; CHINESE; CONTROLLED STUDY; FEMALE; GENOTYPE; HIGH RISK PATIENT; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PROTEIN POLYMORPHISM; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; UTERINE CERVIX CANCER;

ADULT; ALLELES; CHINA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS;

HUMAN PAPILLOMAVIRUS;

EID: 84866382656     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045246     Document Type: Article

References (28)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV, (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244-265.
3. Dranoff G, (2004) Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer 4: 11-22.
4. Wajant H, (2009) The role of TNF in cancer. Results Probl Cell Differ 49: 1-15.
5. Elahi MM, Asotra K, Matata BM, Mastana SS, (2009) Tumor necrosis factor alpha-308 gene locus promoter polymorphism: an analysis of association with health and disease. Biochim Biophys Acta 1792: 163-172.
6. zur Hausen H, (2000) Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 92: 690-698.
7. Polunovsky VA, Wendt CH, Ingbar DH, Peterson MS, Bitterman PB, (1994) Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis. Exp Cell Res 214: 584-594.
8. Ardizzoia A, Lissoni P, Brivio F, Tisi E, Perego MS, et al. (1992) Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease. J Biol Regul Homeost Agents 6: 103-107.
9. Abrahamsson J, Carlsson B, Mellander L, (1993) Tumor necrosis factor-alpha in malignant disease. Am J Pediatr Hematol Oncol 15: 364-369.
10. Mocellin S, Nitti D, (2008) TNF and cancer: the two sides of the coin. Front Biosci 13: 2774-2783.
11. Raabe T, Bukrinsky M, Currie RA, (1998) Relative contribution of transcription and translation to the induction of tumor necrosis factor-alpha by lipopolysaccharide. J Biol Chem 273: 974-980.
12. Kroeger KM, Carville KS, Abraham LJ, (1997) The-308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol Immunol 34: 391-399.
13. Calhoun ES, McGovern RM, Janney CA, Cerhan JR, Iturria SJ, et al. (2002) Host genetic polymorphism analysis in cervical cancer. Clin Chem 48: 1218-1224.
14. Deshpande A, Nolan JP, White PS, Valdez YE, Hunt WC, et al. (2005) TNF-alpha promoter polymorphisms and susceptibility to human papillomavirus 16-associated cervical cancer. J Infect Dis 191: 969-976.
15. Stanczuk GA, Sibanda EN, Tswana SA, Bergstrom S, (2003) Polymorphism at the-308-promoter position of the tumor necrosis factor-alpha (TNF-alpha) gene and cervical cancer. Int J Gynecol Cancer 13: 148-153.
16. Govan VA, Constant D, Hoffman M, Williamson AL, (2006) The allelic distribution of-308 Tumor Necrosis Factor-alpha gene polymorphism in South African women with cervical cancer and control women. BMC Cancer 6: 24.
17. Liu X, Zhang S, Ruan Q, Ji Y, Ma L,et al. Prevalence and type distribution of human papillomavirus in women with cervical lesions in Liaoning Province, China. Int J Gynecol Cancer 20: 147-153.
18. Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, et al. (1995) Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 182: 1259-1264.
19. Azar KK, Tani M, Yasuda H, Sakai A, Inoue M, et al. (2004) Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions. Hum Pathol 35: 1376-1384.
20. Ivansson EL, Juko-Pecirep I, Gyllensten UB, (2010) Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer. Gynecol Oncol 116: 544-548.
21. Singh H, Jain M, Sachan R, Mittal B, (2009) Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter polymorphisms with risk of cervical cancer. Int J Gynecol Cancer 19: 1190-1194.
22. Kirkpatrick A, Bidwell J, van den Brule AJ, Meijer CJ, Pawade J, et al. (2004) TNFalpha polymorphism frequencies in HPV-associated cervical dysplasia. Gynecol Oncol 92: 675-679.
23. Gostout BS, Poland GA, Calhoun ES, Sohni YR, Giuntoli RL 2nd, et al (2003) TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol Oncol 88: 326-332.
24. Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, et al. (2001) The-238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 166: 41-46.
25. Wang SS, Bratti MC, Rodriguez AC, Herrero R, Burk RD, et al. (2009) Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. J Infect Dis 199: 20-30.
26. Liu L, Yang X, Chen X, Kan T, Shen Y, et al. (2011) Association between TNF-alpha polymorphisms and cervical cancer risk: a meta-analysis. Mol Biol Rep.
27. Li N, Franceschi S, Howell-Jones R, Snijders PJ, Clifford GM, (2011) Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int J Cancer 128: 927-935.
28. Lu W, Pan K, Zhang L, Lin D, Miao X, et al. (2005) Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha}and risk of gastric cancer in a Chinese population. Carcinogenesis 26: 631-636.